Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/33047
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | De Castella A.R. | en |
dc.contributor.author | Burger H. | en |
dc.contributor.author | Riedel A. | en |
dc.contributor.author | Rolfe T.J. | en |
dc.contributor.author | Fitzgerald P.B. | en |
dc.contributor.author | Taffe J. | en |
dc.contributor.author | Kulkarni J. | en |
dc.date.accessioned | 2021-05-14T11:12:18Z | en |
dc.date.available | 2021-05-14T11:12:18Z | en |
dc.date.copyright | 2002 | en |
dc.date.created | 20021212 | en |
dc.date.issued | 2012-10-18 | en |
dc.identifier.citation | Archives of Women's Mental Health. 5 (3) (pp 99-104), 2002. Date of Publication: November 2002. | en |
dc.identifier.issn | 1434-1816 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/33047 | en |
dc.description.abstract | A double-blind, 28-day, placebo-controlled study was conducted with three groups of women of child-bearing age (N = 12 in each group) who received standardised antipsychotic medication plus a) 50 mug transdermal estradiol or b) 100 mug transdermal estradiol or c) transdermal placebo. Preliminary analyses show that women receiving 100 mug of estradiol made greater improvements in the symptoms of schizophrenia than either the 50 mug estradiol or placebo groups. The addition of 100 mug adjunctive transdermal oestrogen significantly enhanced treatment responsivity of acute, severe psychotic symptoms in women with schizophrenia. The positive impact of oestrogen treatment on psychotic symptoms via a multiplicity of possible actions (see accompanying articles in this issue) may prove clinically useful in the overall treatment of women with schizophrenia. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Springer Wien (Sachsenplatz 4-6, P.O. Box 89, Vienna A-1201, Austria) | en |
dc.title | A clinical trial of adjunctive oestrogen treatment in women with schizophrenia. | en |
dc.type | Article | en |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00737-002-0001-5 | en |
dc.publisher.place | Austria | en |
dc.identifier.pubmedid | 12510212 [http://www.ncbi.nlm.nih.gov/pubmed/?term=12510212] | en |
dc.identifier.source | 35387787 | en |
dc.identifier.institution | (Kulkarni, Riedel, De Castella, Fitzgerald, Rolfe) Dandenong Psychiat. Research Centre, Monash University, Dept. of Psychological Medicine, Melbourne, Vic., Australia (Taffe) School of Mathematical Sciences, Swinburne University, Melbourne, Vic., Australia (Burger) Prince Henry's Inst. of Med. Res., Monash Medical Centre, Clayton, Vic., Australia (Kulkarni) Alfred Psychiatry Research Centre, Alfred Hospital, Commercial Road, Prahran, Vic. 3181, Australia | en |
dc.description.address | J. Kulkarni, Alfred Psychiatry Research Centre, Alfred Hospital, Commercial Road, Prahran, Vic. 3181, Australia. E-mail: jayashri.kulkarni@med.monash.edu.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2012 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Dopamine Oestrogen/estrogen Prolactin Schizophrenia Serotonin | en |
dc.identifier.authoremail | Kulkarni J.; jayashri.kulkarni@med.monash.edu.au | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Mental Health | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.